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Background: Six species of the genus Entamoeba, i.e., E. histolytica, E. dispar, E. moshkovskii, E. polecki, E. coli, and E.
hartmanii can be found in human stools. Among these, only E. histolytica is considered to be pathogenic, causing
intestinal and extra-intestinal disease, but it is morphologically identical to E. dispar and E. moshkovskii. In general, E.
polecki, E. coli, and E. hartmanii can be differentiated morphologically from E. histolytica, but some of their diagnostic
morphologic features may overlap creating issues for the differential diagnosis. Moreover, the previous inability to
differentiate among Entamoeba species has limited epidemiologic information on E histolytica. The objective of this study
was to develop a rapid, high-throughput screening method using Luminex technique for the simultaneous detection and
differentiation of Entamoeba species.
Methods: PCR amplification was performed with biotinylated Entamoeba sp 18S rRNA gene primers, designed to amplify
a fragment ranging from 382 to 429 bp of the Entamoeba spp studied. Regions of this fragment that could differentiate
among E. histolytica, E. moshkovskii, E. dispar, E. hartmanii and E. coli were selected to design hybridization probes to link
to Luminex beads. The assay was standardized with cloned DNA samples of each species and evaluated with 24 DNA
extracts from samples obtained from individuals diagnosed with these amebas in their stools.
Results: Using this approach we were able to correctly identify E. histoltyica, E. dispar, E hartmanni, E. coli and E. moshkovskii
in all specimens studied. From twenty four samples tested by microscopy, PCR/DNA Sequencing and real-time PCR, 100%
agreed with PCR-Luminex assay for identification of E. dispar, E. moshkovskii, E. hartmanni, E. histolytica, and E. coli.
Conclusion: These results show that this method could be used in the diagnostic detection of Entamoeba spp in fecal
samples. This diagnostic test was useful to clearly distinguish E histolytica from other species and also to strengthen
epidemiologic data on Entamoeba spp.
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The genus Entamoeba contains many species, some of
which (ie, E histolytica, E. dispar, E. moshkovskii, E. polecki,
E. coli and E. hartmanni) can be found in human stools
[1,2]. E. histolytica, thus far, is the only species associated
with disease [2,3]. E. histolytica may cause invasive disease
and extra intestinal amebiasis. It is also evident that not all
humans infected with E. histolytica develop clinical disease* Correspondence: peralta@micro.ufrj.br
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reproduction in any medium, provided the orand in most cases, it may cause mild or asymptomatic
infections [4].
Amoebas may cause a variety of clinical presentations,
from asymptomatic commensal colonization to invasive
amebic dysentery and extraintestinal infections. Infected
individuals may be initially asymptomatic and develop
symptoms later in the course of the infection. Previous
studies have estimated that only one in four E. histolytica
infections progresses to symptomatic [5-8]. Therefore,
WHO recommends that E. histolytica/E. dispar should
be differentiated whenever it is possible and such patients
should not be treated on the basis of microscopy findingsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tively diagnosed or confirmed as being caused by E.
histolytica, should be treated to minimize the risk for
progression to invasive disease. On the other hand, cases
confirmed to involve only E. dispar should not be treated.
If a patient with E. dispar or E. moshkowskii has intestinal
symptoms, a further investigative search should be made
to diagnose other potential causes and in some cases
treatment with drugs effective against protozoan para-
sites will be implemented; e.g. when no other causes are
identified. This is because the traditional methods used
to diagnose amebic infections available in clinical labora-
tories may fail in providing a correct identification to the
species level of ameba parasites. Asymptomatic E.
histolytica infection should be treated with a luminal
amoebicide (diloxanide furoate or paromomycin), and in-
vasive intestinal or extra-intestinal amebiasis should be
handled by administering a tissue amoebicide (metro-
nidazole) followed by luminal treatment (WHO, 1997).
The other Entamoeba species are considered as com-
mensal or non-invasive forms, where no symptoms are
present. Nevertheless, all Entamoeba spp. found in
human stools should be reported in the parasitological
examination. E. hartmanii can be differentiated from other
morphologically similar species primarily based on size. E.
poleckii and E. coli can be differentiated morphologically
from others, but some of their diagnostic morphologic fea-
tures may overlap, depending on the condition of the speci-
men [9]. The diagnosis of amebiasis and the identification
of Entamoeba spp. to the species level are routinely
performed by the identification of the parasite’s morpho-
logic features ascertained through the examination of
stained stool smears. This task might be challenging,
considering that precise identification of such diagnostic
morphologic features require advanced expertise. Despite
all the issues stressed above, the differentiation of E.
histolytica, E. dispar and E. moshkovskii in the stool samples
is the main limitation of microscopy-based diagnosis. Cyst
and trophozoite stages of these species are morphologically
identical. However, all Entamoeba species can be differenti-
ated at the molecular level [10]. Laboratory tests that have
been developed to diagnose amebiasis have focused on the
detection of parasite antigen in the feces by the use of
monoclonal antibodies or based on the detection of parasite
DNA by PCR amplification. A few commercial ELISA kits
are available for detection of E. histolytica, such as the
TechLab Entamoeba test to detect E. histolytica/E. dispar
[11], Alexon ProSpecT ELISA to detect E. histolytica/
E. dispar and Giardia lamblia [12] and a Triage parasite
panel to detect antigen of E. histolytica/E. dispar, Giardia
lamblia and Cryptosporidium parvum in stool specimens
[13]. The main limitation of all these ELISA kits is that they
can identify the amoebae only as E. histolytica/E. dispar
complex but not specifically as E. histolytica, E. dispar orE. moshkovskii. However, a monoclonal antibody based
Tech Lab E. histolytica II ELISA is commercially available
for the specific detection of E. histolytica antigen directly in
stool specimens [11]. During the last decade, a remarkable
development in molecular biology-based procedures to
detect E. histolytica took place. A wide variety of PCR
methods targeting different genes, including 18S rRNA
gene, genes that codify for the 30-kDa antigen, serine-rich
protein, chitinase, hemolysin, and the extra-chromosomal
circular DNA, have been described for the detection and
differentiation of E histolytica, E dispar [14-21] and more
recently E. moshkovskii in human stools [22-24]. However,
some of these studies reported false negative results when
these techniques were compared to microscopy examin-
ation, most of the time when other Entamoeba species;
e.g., E. hartmanii, E. poleckii, E. coli, were present
[7,25-28]. DNA based approaches can be multiplexed to
allow identification of multiple organisms simultaneously.
Recently, there have been an increasing number of multi-
plex assays in the literature, such as PCR followed by
multi-analytical hybridization using fluorescent micro-
spheres as solid supports coupled with flow cytometry.
This technique is able to detect multiple DNA targets in a
single reaction tube. This is possible by the use of sets of
microspheres coupled to probes that hybridize to comple-
mentary PCR-amplified DNA targets. In the Luminex
platform, the hybridized strands on these microspheres
are fluorescently tagged and the beads are individually
analyzed with a red laser that recognizes the microsphere
set, and a green laser that provides readout of the bound
DNA target. This method has been used for the detection
and differentiation of several species of bacteria, fungi,
virus and protozoa [20,29-39]. A Luminex assay for detec-
tion of intestinal parasite DNA was recently standardized,
including E. histolytica [40]. This assay afforded between
83 to 100% of sensitivity and specificity in comparison to
real-time PCR.
In this study we describe the development of a multiplex
direct hybridization assay using a Luminex technology, for
rapid simultaneous detection of E. histolytica, E. dispar,
E. hartmanii, E. moshkovskii and E. coli. Rather than con-
duct a formal evaluation of the molecular approach, we
focused on demonstrating proof of concept. This ap-
proach can be used as a diagnostic method to strengthen




Plasmid DNA containing 18S-rRNA sequences of
E. histolytica, E. dispar, E. moshkovskii, E. hartmanii and
E. coli were used for the initial standardization of the PCR-
based suspension array assay. Amplified PCR products
generated with primers JVF/DSPR2 were purified with
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and cloned using pCR2.1-TOPO vector as described in
the protocol from the TOPO TA cloning Kit (Invitrogen,
Carlsbad, CA,USA) [10].
Samples
A total of 74 DNA extracts from human stools were used
to evaluate the approach. Nine of these DNA extracts were
from stools that were positive for Entamoeba spp by
microscopy, obtained from Brazilian patients. Fifteen add-
itional DNA samples extracted from positive stools sent to
CDC for confirmatory diagnosis of amoebiasis were used in
this study and fifty stool samples with negative direct
parasitological examination were included as a control. All
parasitological positive samples were tested using real-time
PCR and nine Brazilian stools samples were also analyzed
by DNA sequencing as described elsewhere [10,20].
In addition, the specificity of PCR-LUMINEX assay was
evaluated by using 11 DNA samples from other intestinal
parasites: Endolimax nana (n=1), Blastocystis hominis
(n=4), Giardia intestinalis (n=2), Microsporidia (n=1),
Cryptosporidium parvum (n=2) and C. hominis (n=1).
DNA extraction
Total genomic DNA from the clinical samples was
extracted from 300 to 500 μl of human fecal samples, using
the FastDNA method (MP Biomedicals, Solon, OH) com-
bined with the QIAquick PCR purification kit (QIAGEN
Inc., Valencia, CA) as described previously, [41]. Purified
DNA was stored at 4°C until used for the molecular
analysis.
PCR amplification
To amplify the fragments from the 18S rRNA gene, we
used the sets of primer, JVF/DSPRS2, JVF/EntaREV 390
and JFV/Enta417 (Table 1). The reverse primers were syn-
thesized with biotin at the 5′ extremity to allow detection
of hybridized amplicons with fluorescent streptoavidin
moieties. PCR reactions were performed in a 50 μl-volume
containing 20 mM of Tris–HCl pH 8.4; 50 mM of KCl;
1.5 mM of MgCl2; 12 pmoles of each oligonucleotideTable 1 PCR primers and conditions
Generic PCR Primers (5′ -3′) Cycling structure
JVF (forward) GTTGATCCTGCCAGTATTATATG 95°C for 5 min foll
7 min
DSPR2 B (reverse) CACTATTGGAGCTGGAATTAC










*tagged with biotin at the 3′.primer JVF/EntaREV 390; 250 μM of each deoxynucleoside
triphosphate (dNTPs) and 1.25 U of Taq DNA polymerase
(Invitrogen) and 10 μl of DNA sample undiluted and
diluted at 1/10. The PCR amplification reactions were
carried out in a Veriti 96 well thermal cycler (AB Applied
biosystems, Foster City, CA, USA); assay details such as
cycling structure and sequence of primers are outlined in
Table 1. Amplified products were resolved by electrophor-
esis in a 2.0% of agarose gel containing 0.5 μg of ethidium
bromide/ml.
Probe design
DNA sequences of E. histolytica, E. dispar, E. moshkovskii,
E. hartmanni and E. coli deposited in The Genetic
sequence database at the National Center for Biotechnical
Information (NCBI) (GenBank), under accession numbers
X64142, AB197936, Z49256, AF149906, AF149907,
AF149915 and AF149915, respectively, were used to
design the specific hybridization probes. These sequences
were aligned in the GeneStudio suite (GeneStudio, Inc.
Suwannee, GA). Probes were pre-selected based on
results of Basic Local Alignment Search Tool (BLAST)
searches used to verify potential cross-hybridization
with other microorganisms (National Center for Bio-
technology Information, Bethesda, MD; www.ncbi.nlm.
nih.gov) [42]. Oligonucleotide probes were synthesized
with an amino-modified group at the 5′ end and linked
to a 6-carbon linker, as described elsewhere [43]. Each
probe was covalently linked to a specific Luminex
microsphere classification. Signals were only generated
when biotinylated sequences bound to the complemen-
tary probe on the respective microsphere classification.
Secondary structure of the probes was verified by using
the DNA folding application (http://mfold.bioinfo.rpi.
edu/cgi-bin/dna-form1.cgi). To design the probes,
regions prone to secondary structure were avoided
when possible. Probes that would not give the expected
hybridization signal were discarded and new probes
were synthesized and re-tested. The list of probes
designed for specific detection of PCR products are
shown in Table 2.owed by 40 cycles of 95°C for 30 s, 57°C for 30 s, 72 C for 1 min, 72 C for
owed by 40 cycles of 95°C for 30 s, 50°C for 30 s, 72 C for 1 min, 72 C for
owed by 40 cycles of 95°C for 30 s, 55°C for 30 s, 72 C for 1 min, 72 C for
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Briefly, the capture probes modified at the 5′ end with
5-carbon linker and amine were covalently coupled to
carboxylated microspheres (Luminex Corp, Austin, TX,
USA) using a carbodiimide coupling procedure. Individual
sets of microspheres were prepared by placing 200 μl of
stock suspension in a 1.5 ml microcentrifuge tube, the
microspheres were suspended by sonication and vortexed
for approximately 30 seconds, followed by a centrifugation
at 10,000 x g for 1 minute. The supernatant was discarded
and the beads were suspended in 50 μl of 0.1 M MES
(2-N-morpholino-ethanesulfonic acid, Sigma, St Louis,
MO, USA), pH 4.5, using 5 N NaOH. Once suspended,
the beads were vortexed and 2 nmoles of the distinct oli-
gonucleotides were added to the bead mixtures. 2.5 μl of
30 mg/ml freshly prepared N-(3-Dimethylaminopropyl)-
N’-ethylcarbonate (EDC) was immediately added to each
bead-probe mixture to allow the attachment of the amine
modified probe to the carboxylated beads. The micro-
sphere mixtures were incubated in the dark for
30 minutes with continuous shaking. Incubation was re-
peated using a fresh 30 mg/ml solution of EDC and the
microspheres were washed once with 1 ml of 0.02%
polyxyethylenesorbitan monolaurate (Tween 20), theTable 2 List of probes used in this study
Specificiy(ies) Probes
E. histolytica Hist 1
E.histolytica Hist 116
E. histolytica Hist 168
E. histolytica Hist 200






E. dispar Disp 238
E. moshkovskii Emosh 1




E. hartmanni Ehart 1
E. hartmanni Ehart 123
E. coli Ecoli 165
E. coli Ecoli 310
E.histolytica and E. dispar Hist/Disp 275
E. hist, E. disp, E. coli, E. hart, E. mosh EGP 1
E. hist, E. disp, E. coli, E. hart, E. mosh EGP 2beads were vortexed and then centrifuged at 10,000x g for
1 minute. The supernatant was removed and 1 ml of 0.1%
sodium dodecyl sulfate (SDS) was added and the mixture
was vortexed once more. Mixtures were centrifuged at
10,000x g for 1 minute and the supernatant was once
again discarded. Coupled microspheres were stored in
50 μl TE buffer (10 mM Tris- HCl, 1 mM EDTA, pH 8.0)
in the dark at 4°C.
Hybridization assay procedure
The hybridization assay was based on the binding of the
complementary 5′ biotin labeled PCR amplicons to specific
capture probes designed on DNA sequences that could
discriminate among E. coli, E. histoltyica, E dispar, E,
hartmanii, and E, moshkovskii. In addition, an Entamoeba
genus specific probe was used (Table 2). The assay was
performed in a 96-conical well plate (Costar, Corning, NY,
USA). The total reaction volume was 50 μl, which included
33 μl of microsphere mixture and 17 μl of the amplified
product or TE buffer, which was used a blank control. To
prepare the microsphere mixture, the volume of each
microsphere set was calculated and added to 1.5× TMAC
buffer (4.5 M tetramethylammonium chloride, 75mM
























Santos et al. Parasites & Vectors 2013, 6:69 Page 5 of 9
http://www.parasitesandvectors.com/content/6/1/69achieve a concentration of 1500–2500 microspheres per set
in a final volume of 33 μl. PCR products were added to
wells, the titer plate was sealed and the amplified DNA was
denatured at 95°C for 5 min, followed by incubation at
41°C, 43°C, 46°C, 48°C, 50°C, and 52°C for 45 to 60 minutes
in a Veriti 96 well thermal cycler (AB Applied biosystems).
After this incubation, 25 μl of a 1:50 and 1:80 dilution of
pre heated R-phycoerythrin conjugated strepavidin 1mg/ml
(SA-PE Molecular Probes, Eugene, OR, USA) was added to
each well. The plates were tapped and the content of the
wells pipetted up and down. The samples were then incu-
bated for an additional 5, 10 and 15 min at the same
hybridization temperature and then analyzed using the
Luminex platform. Data acquisition, Xponent software
v. 3.0 (Luminex Corp) was used for the analysis. Each
sample was run in duplicate with four blank controls per
plate. The median fluorescent intensity (MFI) of the SA-PE
conjugate bound to 100 of each microsphere population
was reported. The MFI values for samples were corrected
by subtracting the average values of the blank controls.
Cloned samples were used to evaluate the reproducibility of
the assay in five independent repeats.
Ethical approval
This study was reviewed and approved by the Human In-
vestigation Committee of Universidade Federal Fluminense,
Niteroi, Brazil with protocol nº 020/07 for Brazilian sam-
ples. All CDC DNA samples used in this study were
anonymized after submitted to CDC for confirmatory diag-
nosis from state public health laboratories, hospitals and
private clinics in the United States.
Results
The preliminary experiments evaluated the effectiveness of
the primers JVF/DSPR2 targeted to amplify a conserved re-
gion of 18 S rRNA of Entamoeba species, which produced
amplified products ranging from 622 to 667 bp, depending
on the species. In this step cloned DNA samples were amp-
lified from 86 ng/ml E. moshkovskii, 28 ng/ml of E. dispar,
46 ng/mL of E. histolytica, 26 ng/ml of E. hartmanni and
54 ng/mL of E. coli. No amplification was produced when
DNA extracted from Endolimax nana (n=1), Blastocystis
hominis (n=4), Giardia intestinalis (n=2), Microsporidia
(n=1), Cryptosporidium parvum (n=2) and C. hominis
(n=1) were used. To test the multiplex capability of the
Luminex technologyW, beads with probes coupled to them
were pooled together and tested using a single target per
well. The biotinylated PCR amplicons were then hybridized
with a panel of probes linked to specific microsphere
classifications to E. dispar (n=6), E. histolytica (n=5), E.
hartmanni (n=2), E. moshkovskii (n=5) and E. coli (n=2) as
well as group specific probes (n= 3) (Table 1). Preliminary
experiments were designed to evaluate the specificity of the
probes and the stringency conditions necessary todiscriminate among the different species. The optimal
conditions of hybridization assays were determined after a
systematic comparison of different hybridization temper-
atures, incubation times, SA-PE concentrations. Hybrid-
ization experiments were performed testing different
incubation temperatures; i.e., 40°C, 45 °C; 50°C and 55°C
for 30, 45 or 60 minutes. The SA-PE was tested under dilu-
tions of 1:20, 1:80 and 1:50 in 1.5 × TMAC buffer using in-
cubations of 10 and 15 min. The results of hybridization
tests showed low median fluorescence intensity (MIF) for
all probes, in which intensity of signals were close to back-
ground value. We observed that this was due to the pres-
ence of the secondary structure on the biotinylated strand
DNA target located in the region complementary to the
sequences of the probes. Novel reverse primers were
designed targeting the same region. The hybridization
assays with the plasmid-derived PCR biotinylated products
produced by new primers JVF/EntaRev390 and JVF/
Enta417B showed optimum hybridization signal at 46°C for
60 minutes (Figure 1). Followed by the addition of 25 μl of
streptavidin-R-phycoerythtrin solution pre heated in a dilu-
tion of 1:50 in 1 X TMAC buffer, incubated at 46°C for
5 minutes in the dark and analyzed on the Luminex plat-
form W. SA-PE at a 1:50 in 1X TMAC buffer produced
maximum signals with minimum background (Figure 1).
These conditions provided optimal discrimination between
perfect matched and mismatched sequences, generating
highest MIFs for E. dispar, E. moshkovskii, E. hartmanni, E.
coli, except for E. histolytica, which displayed median MIF
(Figure 1) when compared to background. From 23 probes
analyzed only 7 showed a good fluorescence profile, the
probes Hist 116, Dis 238, M3 and Emoshk1, Ecoli310,
Ehart1 and EGP2 hybridized with their respective targets
(Figure 2), with no cross-hybridization. Non-specific
hybridization was seen when the assay was performed at
41°C and 43°C for 60 minutes. Increasing the hybridization
temperature to 48°C reduced the discrimination profile of
E. dispar, E. moshkovskii, and E. histolytica when specific
probes were used. Two different dilution ranges of the
samples were evaluated in this study. Amplicons were
tested using 5 μl of biotinylated amplicons diluted with
12 μl of TE buffer (pH 8) and 17 μl of biotinylated
amplicon diluted 1:100 in TE. Four blank samples were
used in every run. A background well, consisting of all
reaction components except a DNA template was used to
determine the background level of the reporter fluores-
cence associated with each bead. MFI final results were
reported by subtracting the background MFI values from
the sample MFI values. Once the multiplex PCR based
suspension array parameters were determined using the
cloned samples of Entamoeba, this approach was evaluated
with twenty-four DNA extractions obtained from positive
clinical specimens. PCR amplification was performed with
biotinylated Entamoeba sp 18S rRNA gene primers JVS/
Figure 1 Represents hybridization signals obtained from cloned-derived PCR biotinylated products from five Entamoeba species.
(1) 5 μl of biotinylated amplicon diluted with 12 μl of TE buffer (pH 8) and (2) 17 μl of biotinylated amplicon diluted 1:100 in TE were used to
determine the optimal conditions for hybridization and demonstrate that maximal MFI values were obtained with a hybridization temperature of
46°C, hybridization time of 60 min, SA-PE at a dilution of 1:50 preheated. Strains and probes tested were as follows: Microsphere coated with
hist116 (E. histolytica), Dis 238 (E. dispar), Ecoli310 (E. coli), Ehart1 (E. hartmanni ) and Emoshk (E.moshovskii).
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to 429 bp. From these, nine samples were tested by micros-
copy, PCR/DNA Sequencing and real-time PCR tests. The
results obtained from these samples demonstrated an
agreement of 100% among Luminex and PCR/DNA
sequencing for identification of E. dispar, E. moshkovskii,
E. hartmanni, E. histolytica, and E. coli (Table 3), as well
as real-time PCR specific for E. histolytica and E. dispar.
We were able to identify samples with more than one
species of Entamoeba by performing a Luminex assay. AllFigure 2 Location of the probes in strand DNA target. Hist 116, Disp 2
microsphere set hybridized in the region complementary of their respectivfifty parasitologically negative stool samples were negative
in the assay. Of the additional 15 DNA extractions from
stool samples tested, five samples were positive for E.
histolytica, five were positive for E. dispar and five were
negative by real time PCR. The results of the Luminex
assay from these samples showed 100% of concordance
with the real-time PCR. These data demonstrated that the
assay was 100% specific for E. histolytica and E. dispar.
Some of the samples were positive for E. hartmanii by
Luminex assay. The results are shown in Table 4.38, M3 and Emoshk1, Ecoli310, Ehart1 and EGP2 linked on specific
e biotinylated strand DNA target.
Table 4 Results of Luminex assay and real time PCR with













CTL+ Eh_ 1* −41 981 93 140 −89 -
CTL+ Ed_1 1368 54 −61 214 −79 -
CTL+ Em_ 2 −76 −48 547 −45 −86 -
CTL+ Ehart_1 −82 −87 −80 1844 −85 -
CTL+ Ecoli −75 −60 −84 −53 1194 -
Sample 1 530 −15 −64 181 −73 E.dispar
Sample 2 772 −10 −74 728 −76 E.dispar
Sample 3 −77 −76 −71 −79 −68 Negative
Sample 4 −44 1094 135 201 59 E. hist
Sample 5 −43 1144 154 185 75 E. hist
Sample 6 597 −4 −75 578 −80 E.dispar
Sample 7 −79 −70 −77 −89 −87 Negative
Sample 8 −50 1027 101 172 44 E. hist
Sample 9 −39 1144 117 197 49 E. hist
Sample10 −39 1145 172 255 97 E. hist
Sample 11 −85 −69 −86 −94 −93 Negative
Sample 12 −83 −84 −91 −95 −88 Negative
Sample 13 487 −23 −78 394 −73 E.dispar
Sample 14 −75 −69 −81 −78 −71 Negative
Sample 15 530 −11 −65 478 −63 E.dispar
Average
blank***
111 101 116 117 115
*CTL= positive control from cloned-derived PCR biotinylated products.
**Real time PCR specific for E. histolytica and E. dispar.
*** From triplicate.
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Microscopic examination remains the gold standard
method for diagnosing intestinal Entamoeba infection
despite the fact that it cannot differentiate between
E. histolytica, E. moshkovskii and E. dispar. Moreover, E.
polecki, E. coli, and E. hartmanii can be differentiated
morphologically from E. histolytica, but some of their
diagnostic morphologic features overlap depending on
the quality of the smears, creating issues for the differen-
tial diagnostic identification. Microscopy should actually
still be considered as the screening method for the
detection of E. histolytica/E. dispar complex/genus as
well as the other Entamoeba found in human stools.
However, at this time, E. histolytica infections can be
easily confirmed with the use of molecular approaches.
During the last decade, several PCR-based methods and
antigen tests have been developed for the detection of
E. dispar and E. histolytica. However, most of these
platforms have certain limitations when considering its
use in a multiplex format. Multiplexed detection of
Entamoeba spp. could strengthen the diagnosis of ameb-
iasis. Recently a multiplex PCR-bead protocol provided a
sensitive diagnostic screen for a large panel of intestinal
parasites, but included only one species of Entamoeba,
E. histolytica [40].
The main objective of this study was to create a proof of
concept for simultaneous DNA-based detection of patho-
genic and non-pathogenic amebas. In order to accomplish
this goal we developed a Luminex assay for detection and
differentiation of E. histolytica, E. dispar, E. hartmanii,
E. coli, E. moshkovskii. In the future such assays can be
validated for use in clinical diagnosis.
In our study the PCR products were produced with
biotinylated primers and mixed with microspheres that had
been coupled to probes designed on 18SrRNA sequences
that could differentiate Entamoeba species. PCR products,
following hybridization with the beads were incubated withTable 3 Results from real time PCR and DNA sequencing










02/Br E.dispar E.dispar E.dispar; E.coli
03/Br E.dispar E.dispar E.dispar
05/Br E.dispar E.dispar E.dispar
06/Br E.dispar E.dispar E.dispar
15 br Negative E.coli E. coli
17/Br E.dispar E.dispar; E.hart E.dispar; E.hart
18/Br Negative E.hatmanni E.hartmanni
19/Br E.dispar E.dispar; E.hart E.dispar; E.hart
28/Br Negative E.coli E. coli; E.hartstreptavidin–R-phycoerythrin (SAPE), which binds to the
biotin on the PCR amplicons. If the product was present in
the sample, each probe-microsphere set would capture the
specific PCR product. After that, each microsphere was
analyzed in a Luminex instrument capable of identifying
specific color signature of each microsphere as well as
detecting the SAPE bound to the hybridized PCR products.
The primer pair used amplified products that ranged from
622 to 667 bp, according to the Entamoeba species.
However, the hybridization signals obtained from these
amplicons with their respective probes showed low
hybridization signals. The conformation of the amplified
DNA or the presence of secondary structures in the region
of hybridization probes could be the explanation for such
results. Previous studies showed that the length of the
amplicon could influence the hybridization profiles, espe-
cially when showing complex structures prone to the cre-
ation of multiple hairpin loops and stem structures [33].
However, Diaz and Fell [44] found a lower hybridization
signal with the shortest amplicon target and a higher
hybridization signal with amplicon targets of 600 bp and
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optimal hybridization took place when using amplicons of
250-bp. Other studies used amplified products between 100
and 400 bp to minimize the potential steric hindrance
deterrent effect, which affects the efficiency of hybridization
[35]. The authors showed that the antisense primer had to
be re-designed in order to make smaller amplicons and
minimize the chances of secondary structure. JVF/
EntaRev390 and JVF/Enta417 primers produced amplified
products ranging from 382 to 429 nucleotides. The reverse
primer Enta Rev390 has a mismatch of C/T on E. coli
sequence near the 5′ end. However, the efficiency of
amplification was not affected. Some factors affect the spe-
cificity and sensitivity of multiplex hybridization such as
temperature, time and amount of target DNA. We analyzed
5 μl of biotinylated amplicon diluted with 12 μl of TE buffer
(pH 8) and 17 μl of biotinylated amplicon diluted 1:100 in
TE in order to avoid concentration beyond the linear range,
at or near the initial saturation level without sacrificing
discriminations. Optimum hybridization occurred at 46°C
for 1 h. PCR based suspension array parameters were deter-
mined using cloned DNA fragments amplified from
Entamoeba spp. An additional set of Entamoeba positive
clinical isolates were tested. The results shown are strength-
ened by the fact that aliquots of the same sample were used
by other molecular tests. In this study, we used stool sam-
ples positive by real- time PCR, PCR followed by DNA
sequencing analysis and microscopy. There was 100%
agreement between the results of these tests and the identi-
fication derived by the comparative DNA sequencing ana-
lysis, microscopy and real-time PCR combined, thus
yielding an assay specificity of 100%. In addition, the PCR-
based suspension array assay was able to detect
E. hartmanni in stool samples that had more than one
Entamoeba species, but which had not been detected by
microscopic analysis and DNA sequencing analysis. Further
microscopic evaluation using more refined measurement of
the cysts finally revealed the presence of E. hartmanii.
These data suggest that the multiplex Luminex array was
able to provide a very robust discriminatory power in
detecting and differentiating Entamoeba species, even in
mixed infection samples. Concomitant infections with two
or more different Entamoeba are not uncommon, and their
identification may be important for determining the most
appropriate therapy and epidemiological data. Moreover,
mixed infection requires cloning followed by DNA sequen-
cing, which is currently labor-intensive, time-consuming,
and costly. To date, the real-time PCR techniques devel-
oped cannot be used to differentiate all Entamoeba species
found in human stools. There are several merits of the
multiplex system compared to the use of microscopy, real-
time PCR and DNA sequencing analysis. This system re-
duces time, and labor required for Entamoeba detection.
The strength of the assay is that it could also be used todetect the presence of multiple Entamoeba species in the
same reaction vessel.
Conclusion
In conclusion, the assay described here represents a proof
of concept to supplement traditional microscopy in a
routine diagnostic setting. The assay should be a suitable
technique for multiplex identification and differentiation of
E. histolytica, E. dispar, E hartmanni, E. coli and E.
moshkovskii in fecal samples and can refine the diagnosis of
amoebiasis as well as being an important tool in studies
designed to ascertain the distribution of different species of
Entamoeba in human stools.
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